HEXO Corp. HEXO was a big mover
last session, as the company saw its shares rise nearly 7% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This stock, which remained
volatile and traded within the range of $5.26 â$6.00 in the past
one-month time frame, witnessed a sharp increase yesterday.
The upside came after the company has entered into an agreement to
buy Newstrike in an all-stock transaction for roughly $263
million.
The company has seen a mixed track record when it
comes to estimate revisions of no increase and one decrease over
the past few weeks, while the Zacks Consensus Estimate for the
current quarter remained unchanged. The recent price action is
encouraging though, so make sure to keep a close watch on this firm
in the near future.
HEXO currently has a Zacks Rank #3 (Hold) while its Earnings ESP is
positive.
Investors interested in the Medical - Products
industry may consider Bio-Rad Laboratories, Inc. BIO, which has a
Zacks Rank #1 (Strong Buy). You can see the complete list
of todayâs Zacks #1 Rank stocks here.
Is HEXO going up? Or down? Predict to see what others think:Up or
Down
Today's Best Stocks from
Zacks
Would you like to see the updated picks from our best
market-beating strategies? From 2017 through 2018, while the
S&P 500 gained +15.8%, five of our screens returned +38.0%,
+61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From
2000 â 2018, while the S&P averaged +4.8% per year, our top
strategies averaged up to +56.2% per year.
See their latest picks free >>
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free
report
Bio-Rad Laboratories, Inc.
(BIO) : Free Stock Analysis Report
To read this article on
Zacks.com click here.
Zacks Investment Research